The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
- Homepage
- cryptocurrency
- Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet
Related
BitGo Files for IPO With $4.2B in H1 2025 Revenue, $90B in C...
42 minutes ago
0
Michael Saylor: Bitcoin Is Building a Base as 'OG' Sellers E...
45 minutes ago
0
Trending
Popular
© Tayedi Search engine 2025. All rights are reserved